Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes.

Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes. — المؤلف: Kanamori, Takehiro — BMJ open diabetes research & care 2018

المؤلف
Kanamori, Takehiro
النشر
BMJ open diabetes research & care 2018
الوصف
e000588 p.